Cost-Effectiveness of Salmeterol, Fluticasone, and Combination Therapy for COPD
April 2nd 2009This cost-utility analysis compares the cost-effectiveness of salmeterol, fluticasone propionate, combination salmeterolfluticasone, and no maintenance therapy in chronic obstructive pulmonary disease.
Read More
Cost-Effectiveness of Long-Term Oxygen Therapy for Chronic Obstructive Pulmonary Disease
February 14th 2009Continuous home oxygen therapy for chronic obstructive pulmonary disease seems more cost-effective than other health technologies covered by Medicare, while nocturnal oxygen therapy is not.
Read More